Entering text into the input field will update the search result below

Pfizer's shopping cart still has plenty of room

Feb. 06, 2015 9:20 AM ETPfizer Inc. (PFE) StockGSK, BMY, PFE, AGN, AZN, HSP, ABBV, VTRSBy: Douglas W. House, SA News Editor6 Comments
  • According to some observers, Pfizer's (NYSE:PFE) $17B takeout of Hospira (NYSE:HSP) is only a prelude to a bigger deal(s) considering that it was prepared to spend $120B for AstraZeneca (NYSE:AZN).
  • According to Gabelli analyst Kevin Kedra, Actavis Plc (NASDAQ:ACT) is an attractive target, especially since nabbing Allergan (NYSE:AGN) and its fast-growing drug portfolio. A Pfizer takeover would be big enough to overcome the U.S. Treasury's stricter rules on inversions and lower its tax bill.
  • John Boris of SunTrust Banks says GlaxoSmithKline (NYSE:GSK), AbbVie (NYSE:ABBV), Bristol-Myers Squibb (NYSE:BMY) and Mylan (NASDAQ:MYL) may be on the radar as well.
  • Pfizer had $33B in cash at the end of September which it will use a portion of plus debt to pay for Hospira.

Recommended For You

About PFE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PFE--
Pfizer Inc.